No abstract available
Keywords:
ROR1; bispecific T cell engager; chronic lymphocytic leukaemia; ibrutinib; immunotherapy.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology
-
Neoplasm Recurrence, Local / immunology
-
Piperidines
-
Pyrazoles / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Receptor Tyrosine Kinase-like Orphan Receptors / immunology*
-
T-Lymphocytes / immunology*
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents, Immunological
-
Piperidines
-
Pyrazoles
-
Pyrimidines
-
ibrutinib
-
ROR1 protein, human
-
Receptor Tyrosine Kinase-like Orphan Receptors
-
Adenine